Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2/3 Study of Romiplostim in Aplastic Anemia Refractory to or Ineligible for Immunosuppressive Therapy
jRCT2080223188Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label, single-arm trial of romiplostim in aplastic anemia, sponsored by Kyowa Kirin. Started May 2016; status: completed.
02
Drugs
romiplostim
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on jRCT2080223188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223188.